Alpha-methylacyl-CoA racemase: A novel tumor marker over-expressed in several human cancers and their precursor lesions

American Journal of Surgical Pathology

Volumn 26, Issue 7, 2002, Pages 926-931

  Zhou, Ming ^a   Chinnaiyan, Arul M ^a   Kleer, Celina G ^a   Lucas, Peter C ^a   Rubin, Mark A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CCGC 7314 ^*  (United States)

Author keywords

Methyacyl; Breast cancer; CoA racemase (AMACR); Colorectal adenoma; Colorectal cancer; Prostate cancer; Prostatic intraepithelial neoplasia; Tumor marker

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; MITOCHONDRIAL ENZYME; RACEMASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CANCER; COLON TUMOR; COLORECTAL CANCER; DATA BASE; DNA MICROARRAY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRECANCER; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOMA; CARCINOMA; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0036306325     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200207000-00012     Document Type: Article

References (33)

1. Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans
2. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: Emerging evidence for their role as risk modifiers
3. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer
4. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta 12,14-prostaglandin J2
5. Clinical consequences of defects in peroxisomal beta-oxidation
6. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis
7. The pleiotropic functions of peroxisome proliferator-activated receptor gamma
8. Delineation of prognostic biomarkers in prostate cancer
9. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia
10. The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens
11. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy
12. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase
13. Downregulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer
14. P504S: A new molecular marker for the detection of prostate carcinoma
15. Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory
16. Lessons from hereditary colorectal cancer
17. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
18. Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer
19. Intraductal dysplasia: A premalignant lesion of the prostate
20. Patterns of progression in prostate cancer
21. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer
22. Diagnostic uncertainty expressed in prostate needle biopsies. A College of American Pathologists Q-probes study of 15,753 prostate needle biopsies in 332 institutions
23. p63 protein expression is rare in prostate adenocarcinoma: Implications for cancer diagnosis and carcinogenesis
24. Alpha-methylacyl-CoA racemase as a tissue biomarker for prostate cancer
25. Activators of the nuclear receptor PPARgamma enhance colon polyp formation
26. Purification and properties of an alpha-methylacyl-CoA racemase from rat liver
27. Postatrophic hyperplasia of the prostate gland: Neoplastic precursor or innocent bystander?
28. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells
29. Utility of immunohistochemical detection of high molecular weight cytokeratin for differential diagnosis of proliferative conditions of the prostate
30. Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC
31. Peroxisomal fatty acid alpha- and beta-oxidation in humans: Enzymology, peroxisomal metabolite transporters and peroxisomal diseases
32. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis
33. Pristanic acid and phytanic acid: Naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha